Julia Henderson

Two-Year Uitkomsten of the SPARC Fase II-Trial: Simultaneous Focal Boost With Stereotactic Radiotherapie for Localized Prostaatkanker

Radiotherapie plus cisplatine of cetuximab bij laagrisico HPV-positief orofarynxcarcinoom: De-ESCALaTE fase III